Abrdn Healthcare Investors
NYSE:HQHAsset Management
+$0.15 today
- Market cap
- $1.27B
- Beta
- 0.76
- P/E (TTM)
- 4.2
- EPS (TTM)
- $4.72
- Dividend yield
- 11.57%
Volume 0.23M
Average 0.14M
HQH EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Abrdn Healthcare InvestorsNYSE: HQH
EPS (Diluted) · Q4 FY2025 · quarter ended Sep 2025
EPS (Diluted) of $3.17 in Q4 FY2025
Q4 FY2025 EPS (Diluted) was $3.17.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
Sources:Income StatementText generated from reported figures; not investment advice.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 1.84 USD
- Year-over-year change
- -48.2%
- 4-year CAGR
- -14.8%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.84 | -48.2% |
| FY2024 | 2024-12-31 | 3.55 | +211.4% |
| FY2023 | 2023-12-31 | 1.14 | +127.8% |
| FY2022 | 2022-12-31 | (4.10) | -217.5% |
| FY2021 | 2021-12-31 | 3.49 | — |
EPS (Diluted) vs competitors
How HQH compares with its peers on the latest reported figures
- HQH's FY2025 EPS (Diluted) of $1.84 is the 3rd highest of the 10 companies compared; the peer median is $0.71.
- Its year-over-year change of -48.2% is the 8th highest of 10, against a peer median of -31.6%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Mar 2026 | $16.97 | +0.7% | +8.8% | |
| LTM Mar 2026 | $2.06 | -5.9% | — | |
| FY2025 | $1.84 | -48.2% | — | |
KBDCKayne Anderson BDC, Inc. | LTM Mar 2026 | $1.28 | -31.6% | +23.9% |
| LTM Mar 2026 | $1.14 | -36.5% | -2.3% | |
| LTM Mar 2026 | $0.71 | -45.8% | -12.2% | |
| LTM Mar 2026 | $0.67 | -25.4% | +104.6% | |
| LTM Mar 2026 | $0.42 | +422.1% | — | |
| LTM Mar 2026 | $0.04 | -97.1% | +13.1% | |
| LTM Mar 2026 | -$0.59 | -159.0% | -42.6% | |
| Peer median (excluding HQH) | $0.71 | -31.6% | +8.8% | |
Competitors are the stored peer set for HQH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 6.48M | 8.27M | 10.29M | 10.77M | 99.81M |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 6.48M | 8.27M | 10.29M | 10.77M | 99.81M |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 12.71M | 11.94M | 11.48M | 10.99M | 1.14M |
| Operating Expenses | 12.71M | 11.94M | 11.48M | 10.99M | 1.2M |
| Depreciation & Amortization | 6.23M | 3.67M | 1.19M | 220.27K | 0 |
| EBITDA | 0 | 0 | 0 | 0 | 98.61M |
| EBITDA Margin | 0.0% | 0.0% | 0.0% | 0.0% | 98.8% |
| Operating Income | (6.23M) | (3.67M) | (1.19M) | (220.27K) | 98.61M |
| Operating Margin | -96.1% | -44.4% | -11.5% | -2.0% | 98.8% |
| Interest Income | 0 | 112.31K | 620.01K | 2.02M | 1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 161.41M | (190.56M) | 57.52M | 185.17M | 0 |
| Income Before Tax | 155.18M | (194.23M) | 56.33M | 184.95M | 98.61M |
| Pre-Tax Margin | 2394.6% | -2348.4% | 547.4% | 1717.4% | 98.8% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | 155.18M | (194.23M) | 56.33M | 184.95M | 98.61M |
| Net Margin | 2394.6% | -2348.4% | 547.4% | 1717.4% | 98.8% |
| EPS (Basic) | 3.49 | (4.10) | 1.14 | 3.55 | 1.84 |
| EPS (Diluted) | 3.49 | (4.10) | 1.14 | 3.55 | 1.84 |
| Weighted Avg Shares | 45.43M | 47.34M | 49.44M | 52.13M | 53.63M |
| Weighted Avg Shares (Diluted) | 45.43M | 47.34M | 49.44M | 52.13M | 53.63M |
Abrdn Healthcare Investors
NYSE:HQH
Intrinsic Alpha fair value
Locked
Current Price
$22.14
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.